Merz Pharma GmbH & Co. KGaA is an international healthcare company specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Based in Frankfurt am Main, Germany, Merz is a leader in the field of Alzheimer's disease

Alzheimer's disease

Alzheimer's disease also known in medical literature as Alzheimer disease is the most common form of dementia. There is no cure for the disease, which worsens as it progresses, and eventually leads to death...

 research and developed memantine as the first drug for the treatment of moderate to severe Alzheimer's disease. Other franchises covered by Merz are hepatology / metabolic diseases and dermatology (including Mederma

Mederma

Mederma is a topical product used to improve scar appearance. It is a gel based on an onion extract and produced by Merz Pharmaceuticals of Frankfurt, Germany. Mederma's marketing claims it can make scars "softer, smoother, and less noticeable"...

 scar gel). In Asia Pacific, the Merz franchise covers aesthetic dermatology (including Radiesse and Xeomin

Botulinum toxin

Botulinum toxin is a protein produced by the bacterium Clostridium botulinum, and is considered the most powerful neurotoxin ever discovered. Botulinum toxin causes Botulism poisoning, a serious and life-threatening illness in humans and animals...

).

Merz was founded in 1908, has 1700 employees and had 580 million euros of sales in 2008/09. The US subsidiary of Merz is Merz Pharmaceuticals LLC in Greensboro, North Carolina

Greensboro, North Carolina

Greensboro is a city in the U.S. state of North Carolina. It is the third-largest city by population in North Carolina and the largest city in Guilford County and the surrounding Piedmont Triad metropolitan region. According to the 2010 U.S...

.